Ovulation Induction Process in Kyrgyzstan IVF Hospitals: Medication Protocols and Schedule Explained

AI reference summary

Opening: Test report entry point

A sex hormone panel shows FSH 9.8 mIU/mL, AMH 1.2 ng/mL, and antral follicle count of 5–6 in each ovary. These are the results of Ms. Wang, a 42-year-old planning IVF treatment in Kyrgyzstan. Elevated FSH and low AMH indicate diminished ovarian reserve, requiring a more individualized ovulation induction protocol. After consulting several reproductive centers in Bishkek, she received three different recommendations — some suggested an antagonist protocol, others mild stimulation, and some even recommended directly considering a follicular phase long protocol. Why would the same report lead to different plans? What exactly is the ovulation induction process in Kyrgyzstan?

Core Process of Ovulation Induction in Kyrgyzstan IVF

In Kyrgyzstan reproductive centers, the ovulation induction process follows international standard frameworks, but specific execution details vary slightly depending on hospital and physician practice. The standard process includes:

• Start timing: Cycle day 2–4, after transvaginal ultrasound confirms no residual follicles or cysts.
• Gonadotropin administration: Daily subcutaneous injection of recombinant FSH (Gonal-f, Puregon, or equivalent) or urinary FSH (Menopur), with starting dose determined by age, AMH, FSH, and antral follicle count. Typically 75–300 IU/day.
• Monitoring points: First monitoring on day 5–6 of medication, then transvaginal ultrasound and serum E2, LH, P4 levels every 1–3 days.
• Antagonist addition: When the leading follicle reaches 12–14 mm or E2 levels rise rapidly, a GnRH antagonist (Cetrotide or Ganirelix) is added to prevent premature ovulation.
• Trigger: When the leading follicle is ≥18 mm and at least 2–3 follicles are ≥17 mm, hCG (Ovidrel or equivalent) or GnRH agonist (Decapeptyl) is administered to trigger final maturation.
• Egg retrieval: 34–36 hours after trigger, under transvaginal ultrasound guidance.

The entire stimulation cycle typically lasts 10–14 days, depending on follicle growth rate and protocol type.

Key Pre-Stimulation Indicators and Protocol Selection Logic

Before formulating an ovulation induction protocol, reproductive physicians focus on interpreting the following indicators:

These indicators are not viewed in isolation; the physician comprehensively evaluates them before determining the starting dose and protocol type. The same AMH value may lead to completely different medication strategies in individuals of different ages and with different prior response histories.

Reproductive Physician Perspective: Why Different Protocols for the Same Report?

Physicians who have worked in different reproductive centers in Kyrgyzstan have subtle differences in their approach to ovulation induction. Some doctors prefer a conservative start with gradual dose increase, believing this reduces OHSS risk, especially suitable for Asian populations. Others advocate for a full starting dose with early trigger, arguing this shortens the cycle and reduces follicular asynchrony.

From clinical outcomes, both approaches have their appropriate populations. For patients with normal ovarian reserve (AMH 1.5–3.5 ng/mL, FSH < 8 mIU/mL) and age ≤35, there is no significant difference in success rates between the two. However, for those with low AMH or advanced age, the conservative start carries a slightly higher risk of cycle cancellation, while the full-dose start carries a slightly higher OHSS risk.

In several major reproductive centers in Bishkek, the antagonist protocol is the absolute mainstream, accounting for over 80% of stimulation protocols. Long and short protocols are only used for specific populations — for example, those with previous PCOS and high OHSS risk might use a long protocol for pre-suppression, but it is now rarely a first-line choice.

Ovulation Induction Characteristics of Different Reproductive Centers in Kyrgyzstan

Although the process framework is similar, on-site observation reveals some operational differences:

In terms of medication choice, recombinant FSH and urinary FSH show no significant difference in clinical pregnancy rates, but urinary FSH has slightly higher LH activity, which may be advantageous for patients with low LH. In terms of cost, urinary FSH is usually 15–25% cheaper.

Detailed Timeline of an Ovulation Induction Cycle

Below is a typical antagonist protocol schedule (using a 28-day menstrual cycle as an example):

• Day 1: Menstrual bleeding (call the center to schedule start)
• Day 2–4: Visit clinic for transvaginal ultrasound + hormone tests, confirm start conditions, begin gonadotropin injections
• Day 5–6: First follicle monitoring (ultrasound + E2/LH), adjust dose based on follicular response
• Day 8–10: Follicle diameter reaches 12–14 mm, add antagonist, continue monitoring
• Day 11–13: Follicle diameter reaches 17–18 mm, E2 levels match follicle count, administer trigger medication
• Day 13–15 (34–36h after trigger): Egg retrieval surgery

This timeline is ideal; in practice, about 30% of patients require protocol adjustments due to follicles growing too fast or too slow. For example, those with slow follicle growth may need stimulation extended to 16–18 days, while those with PCOS tendency may reach trigger criteria in 8–9 days.

Most Easily Overlooked Details During Ovulation Induction

From practical clinical experience, several points often catch people unprepared after arriving in Kyrgyzstan:

• Medication storage temperature: Gonadotropins require refrigeration at 2–8°C. If you do not carry a cooling pack when picking up medication from the pharmacy, efficacy may decrease. Summer temperatures in Bishkek can exceed 35°C; ice packs are needed during travel to and from the hospital.
• Consistency of injection time: Daily injection time should be fixed (within 1 hour), otherwise it affects follicular development synchrony. After adjusting for time zone changes, it is easy to miss or delay injections.
• Timing of antagonist addition: Some center physicians habitually wait until follicles reach 14 mm to add the antagonist, but patients with early LH rise may show signs of premature ovulation at 12 mm, requiring earlier addition.
• Fasting and fluid restriction before egg retrieval: Egg retrieval requires intravenous anesthesia, typically requiring fasting for 6–8 hours and no fluids for 2 hours. If the surgery time is uncertain, preparation can be inadequate.

Time Commitment and Rhythm Planning During the Stimulation Phase

The stimulation phase requires a stay in Kyrgyzstan of at least 14–18 days. Specific time allocation:

• Start-up period: 2–3 days (first clinic visit, medication pickup, learning injections)
• Medication and monitoring period: 10–14 days (clinic visits every 1–3 days, rest at accommodation the rest of the time)
• Egg retrieval and recovery: 2–3 days (retrieval surgery + post-operative observation)

If using a mild stimulation protocol, the stay may be shortened to 10–12 days, but the number of eggs retrieved is usually lower. It is recommended to reserve at least 16 days in case of slow follicle growth requiring extended medication.

Frequently Asked Questions from Patients

• Can I fly during the stimulation phase? — Long-distance flights are not recommended from the start of stimulation until after egg retrieval. In the late follicular phase (≥14 mm), changes in air pressure and prolonged sitting may increase the risk of ovarian torsion.
• Are there dietary precautions during stimulation? — No special dietary supplements are needed; a balanced diet is sufficient. High-protein foods (fish, eggs, lean meat) may support follicle quality, but excessive intake is unnecessary. Avoid alcohol and strenuous exercise.
• Why is my follicle count lower than expected? — Individual response to medication varies greatly. AMH and AFC only predict a general range; the actual number of eggs retrieved is typically 30–50% lower than the AFC. If response is poor, your doctor may adjust the protocol or change cycle strategy.
• Does the antagonist protocol reduce success rates? — Current large-scale studies show no significant difference in clinical pregnancy rates between antagonist and long protocols, but the antagonist protocol has a lower OHSS risk and shorter cycle duration. For PCOS and normal reserve patients, the antagonist protocol is already the first choice.

Related reading directions: What medications are used for ovulation induction in Kyrgyzstan IVF · How long does ovulation induction take · Precautions during ovulation induction · Can I still do IVF in Kyrgyzstan with low AMH · What to prepare for advanced maternal age IVF in Bishkek · Do I need to prepare before ovulation induction · Documents and visa preparation for IVF in Kyrgyzstan